Abstract
The clinical utility of these markers will have to be confirmed and validated in large clinical trials before they are accepted as surrogate markers for the development of vasculopathy.
Original language | English (US) |
---|---|
Pages (from-to) | 443-447 |
Number of pages | 5 |
Journal | Current opinion in organ transplantation |
Volume | 9 |
Issue number | 4 |
DOIs | |
State | Published - Dec 2004 |
Keywords
- Heart transplantation
- Surrogate
- Transplant vasculopathy
ASJC Scopus subject areas
- Immunology and Allergy
- Transplantation